← SynDRA
LUMEFANTRINE
SynDRA canonical compound SYN0002024 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | ATP1A1 |
| Mechanism of action | antimalarial agent |
| Indication | malaria |
| Disease area | infectious disease |
All known targets
Mechanisms of action (all sources)
- antimalarial agent
- ATP1A1 BINDER
Drug classes
- Antimalarial
- Anti-Infective Agents
- Antimalarials
- Antiparasitic Agents
- Antiprotozoal Agents
ATC classes
Cross-references
Synonyms
- benflumelol
- benflumetol
- Lumefantrina
- Benflumelol
- Benflumetol
- Dl-benflumelol
- Lumefantrinum
- CPG-56695
- GNF-PF-1971
- Lumefantrine component of coartem
- Coartem
- Dl-Benflumelol
- Lumefantrine (INN)
- Lumefantrine [INN:BAN]
- (+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-alpha((dibutylamino)methyl)fluorene-4-methanol
- (+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-alpha-((dibutylamino)methyl)fluorene-4-methanol
- 2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl]ethanol
- 2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]fluoren-4-yl]ethanol
- 2-Dibutylamino-1-[2,7-dichloro-9-(4-chloro-benzylidene)-9H-fluoren-4-yl]-ethanol
- 2-Dibutylamino-1-{2,7-dichloro-9-[1-(4-chloro-phenyl)-meth-(Z)-ylidene]-9H-fluoren-4-yl}-ethanol
- GNF-Pf-1971
- F38R0JR742
- DTXCID1026663
- CHEBI:156095
- COARTEM COMPONENT LUMEFANTRINE
- RefChem:800121
- dl-Benflumelol
- Lumefantrine, (+)-
- Lumefantrine, (-)-
- C30H32Cl3NO
- D-Benflumelol
- L-Benflumelol
- MFCD05662268
- ZUV4B00D9P
- NCGC00167490-01
- CAS-82186-77-4
- Lumefruntrine
- UNII-F38R0JR742
Reported adverse events
- Abdominal pain
- Arthralgia
- Aspartate aminotransferase increased
- Asthenia
- Chills
- Cough
- Dizziness
- Fatigue
- Headache
- Hepatomegaly
- Hypersensitivity
- Infection
Look up LUMEFANTRINE in the interactive SynDRA portal →